A simple segue from Sanger to high-throughput SMRT Sequencing with a M13 barcoding system

Author(s): Larrea, Andres and Yuan, George and Wagner, Kimberly and Butt, Bryan and Norvell, Brian and Aro, Lori and Gu, Jenny and Lleras, Roberto and Randade, Swati and Korlach, Jonas and Krueger, Brian and Heiner, Cheryl

High-throughput NGS methods are increasingly utilized in the clinical genomics market. However, short-read sequencing data continues to remain challenged by mapping inaccuracies in low complexity regions or regions of high homology and may not provide adequate coverage within GC-rich regions of the genome. Thus, the use of Sanger sequencing remains popular in many clinical sequencing labs as the gold standard approach for orthogonal validation of variants and to interrogate missed regions poorly covered by second-generation sequencing. The use of Sanger sequencing can be less than ideal, as it can be costly for high volume assays and projects. Additionally, Sanger sequencing generates read lengths shorter than the region of interest, which limits its ability to accurately phase allelic variants. High-throughput SMRT Sequencing overcomes the challenges of both the first- and second-generation sequencing methods. PacBio’s long read capability allows sequencing of full-length amplicons

Organization: PacBio
Year: 2018

View Conference Poster




在本网页上注册,即表示您同意,并同意 PacBio 根据我们的隐私政策收集和使用该信息.